Abstract

The pulsatile-release Chronotopic™ system was conceived of as a drug-containing core surrounded by a coat made of swellable/soluble hydrophilic polymers, the latter being able to provide a programmable lag phase prior to drug liberation. This system was also proposed in a colon-targeting configuration, entailing a gastroresistant film to prevent early interaction of the inner coat with gastric fluids and enabling the attainment of a lag phase matching the small intestinal transit time. Over the years, various multiple-step manufacturing processes have been tested for the fabrication of the Chronotopic™ system in both its configurations. This work focused on the evaluation of 3D printing by fused deposition modeling in view of its potential towards product personalization, on demand one-step manufacturing and efficient scale down of batches. The feasibility of each part of the Chronotopic™ system was independently investigated starting from in-house made filaments, characterizing the resulting specimens for physico-technological and performance characteristics. The printing parameters identified as suitable during the set-up phase were then used to fabricate prototypes either in a single step for the pulsatile configuration or following two different fabrication approaches for the colon-targeting one.

Highlights

  • Chronopharmaceutics relates to the development of drug delivery systems (DDSs) able to control the release of an active ingredient conveyed according to a body’s biological rhythms, having, as its ultimate goal, the improvement of compliance, efficacy and efficiency of pharmacological treatment [1,2]

  • The ChronotopicTM system in the pulsatile-release configuration consists in a drugcontaining core surrounded by a polymeric barrier able to defer its interaction with aqueous fluids

  • With the aim of fabricating this system by fused deposition modeling (FDM), a printer equipped with two independent arms able to work simultaneously or alternately, with diverse materials and under different process conditions, was employed. 3D printed items are fabricated through deposition of subsequent layers, which can be made of the same or of different materials/formulations

Read more

Summary

Introduction

Chronopharmaceutics relates to the development of drug delivery systems (DDSs) able to control the release of an active ingredient conveyed according to a body’s biological rhythms, having, as its ultimate goal, the improvement of compliance, efficacy and efficiency of pharmacological treatment [1,2]. These DDSs are generally designed to enable one or more lag phases of programmable duration prior to drug release, being referred to as pulsatile- or delayed-release systems [3,4]. Oral pulsatile DDSs that provide lag phases matching the small intestine transit time, which has been demonstrated to be fairly consistent

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call